ADMA Projected Dividend Yield
ADMA Biologics Inc ( NASDAQ : ADMA )ADMA Biologics, Inc. is a biopharmaceutical company focused on manufacturing, marketing, and developing specialty biologics for immunodeficient patients and those at risk for infectious diseases. It produces and markets three FDA-approved plasma-derived biologics: BIVIGAM for primary humoral immunodeficiency (PI), ASCENIV for PI, and NABI-HB for enhanced immunity against hepatitis B. Additionally, through its ADMA BioCenters subsidiary, the company operates as an FDA-approved plasma collector in the U.S., supplying blood plasma for its products. 21 YEAR PERFORMANCE RESULTS |
|
ADMA Dividend History Detail ADMA Dividend News ADMA Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |
